Antiviral nucleoside derivatives

C - Chemistry – Metallurgy – 07 – H

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07H 19/167 (2006.01) A61K 31/70 (2006.01) A61P 31/14 (2006.01)

Patent

CA 2504846

The present invention relates to nucleoside derivatives for the treatment of Hepatitis C viral infections including compounds of formula I (I), to pharmaceutical compositions comprising these compounds and methods for treatment or prophylaxis of Hepatitis C Virus mediated diseases employing said compounds in monotherapy or in combination therapy. The present invention further provides a process for preparing 1',3',4'-triacyl pyrimidine nucleoside from a N,1',3',4'-tetraacylpyrimidine nucleoside.

La présente invention concerne des dérivés nucléosidiques destinés au traitement d'infections par le virus de l'hépatite C, y compris des composés représentés par la formule générale (I), des compositions pharmaceutiques comprenant ces composés et des méthodes destinées au traitement ou à la prévention de maladies induites par le virus de l'hépatite C faisant intervenir ces composés en monothérapie ou en polythérapie. La présente invention concerne également un procédé destiné à la préparation d'un nucléoside de 1',3',4'-triacyl pyrimidine à partir d'un nucléoside de N,1',3',4'-tétraacylpyrimidine.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Antiviral nucleoside derivatives does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Antiviral nucleoside derivatives, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Antiviral nucleoside derivatives will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1559171

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.